Abstract
IntroductionSomatostatin has antitumour activity in animal models of hepatocellular carcinoma. In human studies both favourable and unfavourable results have been reported. A 40% fraction of treated patients are benefited. Since...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
